Tumefactive multiple sclerosis

Contributors
Article section 12 of 12.  Previous  

By Reem F Bunyan MD and Claudia F Lucchinetti MD

Reem F Bunyan MD, author. Dr. Bunyan of the Mayo Clinic Department of Neurology has no relevant financial relationships to disclose.

Claudia F Lucchinetti MD, author. Dr. Lucchinetti of the Mayo Clinic Department of Neurology has no relevant financial relationships to disclose.

Anthony T Reder MD, editor. Dr. Reder has served on advisory boards and as a consultant for Bayer, Berlex Laboratories, BioMS Medical Corp, Biogen Idec, Caremark Rx, Lilly, Neurocrine Biosciences, Novartis, Pfizer, Schering, Serono, and Teva Marion.

In This Article

Introduction
Historical note and nomenclature
Clinical manifestations
Clinical vignette
Pathogenesis and pathophysiology
Epidemiology
Differential diagnosis
Diagnostic workup
Prognosis and complications
Management
References cited
Contributors